EXHIBIT 99.1
Published on May 30, 2013
Exhibit 99.1
NOTICE DECLARING INTENTION TO BE QUALIFIED
UNDER NATIONAL INSTRUMENT 44-101
SHORT FORM PROSPECTUS DISTRIBUTIONS (“NI 44-101”)
May 29, 2013
|
To:
|
Autorité des marchés financiers, as notice regulator, and each of the other securities regulators in the provinces of Canada where the Issuer is a reporting issuer
|
Acasti Pharma Inc. (the “Issuer”) intends to be qualified to file a short form prospectus under NI 44-101. The Issuer acknowledges that it must satisfy all applicable qualification criteria prior to filing a preliminary short form prospectus. This notice does not evidence the Issuer’s intent to file a short form prospectus, to enter into any particular financing or transaction or to become a reporting issuer in any jurisdiction. This notice will remain in effect until withdrawn by the Issuer.
|
ACASTI PHARMA INC.
|
|||
|
By:
|
(signed) Xavier Harland
|
||
|
Xavier Harland
|
|||
|
Chief Financial Officer
|
|||